Research Paper Volume 16, Issue 6 pp 5545—5566
A pyrimidine metabolism-related signature for prognostic and immunotherapeutic response prediction in hepatocellular carcinoma by integrating analyses
Figure 5. The distribution features and the OS KM curve of various clinicopathological factors in different risk groups. (A–C) Age, (D–F) Gender, (G–I) Grade, (J–L) Stage, (M–O) T.